Skip to main content

Andrew Benjamin Nixon

Professor in Medicine
Medicine, Medical Oncology
Duke Box 2631, Durham, NC 27710
133 Jones, Research Drive, Durham, NC 27710

Overview


Dr. Andrew Nixon is Professor of Medicine in the Department of Medicine/Division of Medical Oncology at Duke University. He holds a BS in chemistry from Miami University, a PhD in biochemistry from Wake Forest University, and an MBA with a focus on healthcare management from Duke University/Fuqua School of Business. He is a nationally recognized expert in the development of cancer biomarkers and correlative science, with extensive experience leading large multi-center biomarker analyses. Dr. …

Current Appointments & Affiliations


Professor in Medicine · 2021 - Present Medicine, Medical Oncology, Medicine
Member of the Duke Cancer Institute · 1998 - Present Duke Cancer Institute, Institutes and Centers

Recent Publications


Randomized Phase II Study of Bevacizumab with Weekly Anetumab Ravtansine or Weekly Paclitaxel in Platinum-Resistant/Refractory High-Grade Ovarian Cancer (NCI Trial).

Journal Article Clin Cancer Res · March 17, 2025 PURPOSE: Mesothelin (MSLN) is highly expressed in high-grade serous/endometrioid ovarian cancers (HGOC). Anetumab ravtansine (AR) is an antibody-drug conjugate directed at the MSLN antigen with a tubulin polymerization inhibitor. We assessed the safety, ac ... Full text Link to item Cite

Characterization of the Biological Variability of the Angiome Biomarkers over Time in Healthy Participants.

Journal Article Cancer Epidemiol Biomarkers Prev · January 9, 2025 BACKGROUND: Biomarker analyses are an integral part of cancer research. Despite the intense efforts to identify and characterize biomarkers in patients with cancer, little is known regarding the natural variation of biomarkers in healthy populations. Here ... Full text Link to item Cite

Supplementary Table S5 from Characterization of the Biological Variability of the Angiome Biomarkers over Time in Healthy Participants

Other · January 9, 2025 <p>Supplementary Table S5 shows three potential measures of variance.</p> ... Full text Cite
View All Publications

Recent Grants


Targeting Hepatocyte Senescence to Improve NAFLD

ResearchAdvisor · Awarded by National Institute of Diabetes and Digestive and Kidney Diseases · 2024 - 2029

Drug Development for Dystonia

ResearchCo Investigator · Awarded by Department of Defense · 2023 - 2027

Duke ACS Institutional Research Grant

ResearchSignificant Contributor · Awarded by American Cancer Society, Inc. · 2024 - 2026

View All Grants

Education, Training & Certifications


Duke University · 2007 M.B.A.
Wake Forest University · 1997 Ph.D.